Clinical Trials Browser

Phase 2 × Peripheral Nervous System Diseases × Hydroxychloroquine × Clear all

NCT05689359 2024-03-08

Evaluation of Hydroxychloroquine to Prevent CIPN

Phase 2 Withdrawn

Breast Neoplasms, Peripheral Nervous System Diseases